Eu-BRD2 transgenic mice that develop B cell lymphoma

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		03-37
IP Type:		Licensable Technology
Title:		Eu-BRD2 transgenic mice that develop B cell lymphoma
Inventor:		Faller, Douglas V.
Summary:		A transgenic mouse model for B cell lymphoma for basic research. This model can be used to search for novel biomarkers of human cancers and as a system for testing anti-cancer pharmaceuticals.
Tech Type:		Research Reagents
URL:		http://ctf-fmfe.bu.edu/BU0337.pdf
Contact:		Rick T. Clark, cives@bu.edu, 617 358 4550
Organization:		Boston University

Display all intellectual properties for Faller, Douglas V.
Display all intellectual properties for Boston University